NCT03655691已完成2 期
Clinical Trial to Evaluate ET-01 in Subjects With Lateral Canthal Lines
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 79
- 试验地点
- 12
- 主要终点
- Number of Participants With a Response Defined as Change in IGA-C (Investigators Global Assessment) Score by at Least 2 Ordinals From Baseline to Week 4
研究概览
简要总结
This study tests an investigational drug formulation called ET-01, botulinum toxin, Type A, topical, in lateral canthal lines (LCL).
详细描述
This product is being tested for its ability to reduce lateral canthal lines, also known as Crow's Feet.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
盲法说明
different doses are packaged in identical containers
入排标准
- 年龄范围
- 25 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •25 - 65 years of age
- •minimal to moderate Crow's Feet wrinkles at rest
- •moderate to severe Crow's Feet wrinkles on contraction
- •willingness to refrain from any product affecting skin remodeling
- •female subjects must be not pregnant and non-lactating
排除标准
- •history of adverse reactions to any prior botulinum toxin treatments
- •history of vaccination or non-response to any prior botulinum toxin treatments
- •botulinum toxin treatment in the prior 6 months
- •present or history of neuromuscular disease, eyelid ptosis, muscle weakness, paralysis, or "dry eye"
- •history of peri-ocular surgery, brow lift or related procedures
- •procedures affecting the lateral canthal region in the prior 12 months
- •application of topical prescription medication to the treatment area
- •female subjects who are pregnant or are nursing a child
结局指标
主要结局
Number of Participants With a Response Defined as Change in IGA-C (Investigators Global Assessment) Score by at Least 2 Ordinals From Baseline to Week 4
时间窗: Week 4
Investigators Global Assessment of the Crow's Feet Wrinkle Scale where severity is scored between 0-4 (0=absent; 4=severe). Response is defined as change by at least two ordinals from Baseline to Week 4.
次要结局
- Total Number of Observations With a Response Defined as SSA-C Score ≤ 2 at Any Time Between Week 2 and Week 18(Week 2, 4, 8,12, and 18)
- Total Number of Observations With a Response Defined as IGA-C Score ≤ 2 at Any Time Between Week 2 and Week 18(Week 2, 4, 8,12, and 18)
研究者
研究点 (12)
Loading locations...
相似试验
已完成
2 期
ET-01 in Subjects With Lateral Canthal Lines, LCL-208Lateral Canthal LinesCrow's FeetNCT03839693Eirion Therapeutics Inc.75
已完成
2 期
ET-01 in Subjects With Lateral Canthal Lines, LCL-209Lateral Canthal Lines, LCLCrow's FeetNCT03912805Eirion Therapeutics Inc.38
已完成
2 期
ET-01 in Subjects With Lateral Canthal LinesLateral Canthal LinesCrow's FeetNCT03326856Eirion Therapeutics Inc.48
已完成
2 期
ET-01 in Subjects With Lateral Canthal Lines, LCL-210Lateral Canthal Lines, LCLCrow's FeetNCT04985916Eirion Therapeutics Inc.280
已完成
1 期
Botulinum Toxin to Treat Restless Legs SyndromeRestless Legs SyndromeNCT00479154National Institute of Neurological Disorders and Stroke (NINDS)6